Platelets Effects on Tumor Growth

被引:83
作者
Goubran, Hadi A. [1 ,2 ]
Stakiw, Julie [1 ,2 ]
Radosevic, Mirjana [3 ]
Bumouf, Thierry [4 ]
机构
[1] Univ Saskatchewan, Saskatoon Canc Ctr, Saskatoon, SK S7N 0W0, Canada
[2] Univ Saskatchewan, Dept Med, Coll Med, Div Oncol, Saskatoon, SK S7N 0W0, Canada
[3] Human Prot Proc Sci, Lille, France
[4] Taipei Med Univ, Coll Oral Med, Inst Biomed Mat & Tissue Engn, Taipei, Taiwan
关键词
LOW-DOSE ASPIRIN; P-SELECTIN; ENDOTHELIAL BARRIER; P2Y(12) RECEPTOR; CANCER-CELLS; AGGREGATION; METASTASIS; MECHANISMS; VEGF; ACTIVATION;
D O I
10.1053/j.seminoncol.2014.04.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Unlike other blood cells, platelets are small anucleate structures derived from marrow megakaryocytes. Thought for almost a century to possess solely hemostatic potentials, platelets, however, play a much wider role in tissue regeneration and repair and interact intimately with tumor cells. On one hand, tumor cells induce platelet aggregation (TCIPA), known to act as the trigger of cancer-associated thrombosis. On the other hand, platelets recruited to the tumor microenvironment interact, directly, with tumor cells, favoring their proliferation, and, indirectly, through the release of a wide palette of growth factors, including angiogenic and mitogenic proteins. In addition, the role of platelets is not solely confined to the primary tumor site. Indeed, they escort tumor cells, helping their intravasation, vascular migration, arrest, and extravasation to the tissues to form distant metastasis. As expected, nonspecific or specific inhibition of platelets and their content represents an attractive novel approach in the fight against cancer. This review illustrates the role played by platelets at primary tumor sites and in the various stages of the metastatic process. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:359 / 369
页数:11
相关论文
共 84 条
[71]  
Sharif Pooneh Salari, 2010, Inflammation & Allergy Drug Targets, V9, P393
[72]   Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer [J].
Sharma, Deva ;
Brummel-Ziedins, Kathleen E. ;
Bouchard, Beth A. ;
Holmes, Chris E. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (08) :1005-1015
[73]  
Shim YK, 2013, BLOOD
[74]  
Smyth S, 2010, PLATELET MORPHOPHOLO, P1735
[75]   Essential in Vivo Roles of the C-type Lectin Receptor CLEC-2 EMBRYONIC/NEONATAL LETHALITY OF CLEC-2-DEFICIENT MICE BY BLOOD/LYMPHATIC MISCONNECTIONS AND IMPAIRED THROMBUS FORMATION OF CLEC-2-DEFICIENT PLATELETS [J].
Suzuki-Inoue, Katsue ;
Inoue, Osamu ;
Ding, Guo ;
Nishimura, Satoshi ;
Hokamura, Kazuya ;
Eto, Koji ;
Kashiwagi, Hirokazu ;
Tomiyama, Yoshiaki ;
Yatomi, Yutaka ;
Umemura, Kazuo ;
Shin, Yonchol ;
Hirashima, Masanori ;
Ozaki, Yukio .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (32) :24494-24507
[76]   Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2 [J].
Takagi, Satoshi ;
Sato, Shigeo ;
Oh-hara, Tomoko ;
Takami, Miho ;
Koike, Sumie ;
Mishima, Yuji ;
Hatake, Kiyohiko ;
Fujita, Naoya .
PLOS ONE, 2013, 8 (08)
[77]   Malignant cells, directors of the malignant process: Role of transforming growth factor-beta [J].
Teicher, BA .
CANCER AND METASTASIS REVIEWS, 2001, 20 (1-2) :133-143
[78]   ASPIRIN USE AND REDUCED RISK OF FATAL COLON CANCER [J].
THUN, MJ ;
NAMBOODIRI, MM ;
HEATH, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (23) :1593-1596
[79]   Role of P-selectin and PSGL-I in coagulation and thrombosis [J].
Vandendries, ER ;
Furie, BC ;
Furie, B .
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (03) :459-466
[80]   Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration [J].
Varon, David ;
Hayon, Yael ;
Dashevsky, Olga ;
Shai, Ela .
THROMBOSIS RESEARCH, 2012, 130 :S98-S99